Supports clinical oncology trials in cancer prevention and control in community settings. Funds investigator-initiated research in supportive, palliative and end-of-life care. Coordinates with other NCI programs to conduct clinical oncology research projects in the community setting.
On This Page
- All Headings will automatically be pulled in to this list.
- Do not edit the content on this template.
Major Programs
Staff List
| Name, Email, Phone | Room | Group(s)/Office |
|---|---|---|
| Heckman-Stoddard, Brandy, Ph.D., M.P.H. brandy.heckman-stoddard@nih.gov 240-276-7048 |
5E334 | Chief
|
Breast and Gynecologic Cancer
Acting Chief | Community Oncology and Prevention Trials |
| Lee, Beverly beverly.lee@nih.gov 240-614-3425 |
5E532 | Program Officer | Community Oncology and Prevention Trials |
| Lee, Cecilia, Dr.P.H., RN cecilia.lee@nih.gov 240-276-7152 |
5E516 | Nurse Consultant | Community Oncology and Prevention Trials |
| Maxwell, Pamela pamela.maxwell@nih.gov 240-276-7081 |
5E434 | Program Specialist | Community Oncology and Prevention Trials |
| McCarty, Larae larae.mccarty@nih.gov 240-276-5777 |
5E322 | Program Specialist
|
Community Oncology and Prevention Trials
Early Detection |
| Parker, Bernard, M.D., FACP bernard.parker@nih.gov 240-276-5533 |
5E448 | Program Officer | Community Oncology and Prevention Trials |
| Streck, Brennan, Ph.D., RN, M.P.H. brennan.streck@nih.gov 240-276-7050 |
5E430 | Program Officer
|
Breast and Gynecologic Cancer
Program Officer | Community Oncology and Prevention Trials |
| White, Vanessa A., M.P.H. vanessa.white@nih.gov 240-276-6163 |
5E524 | Program Officer
|
Breast and Gynecologic Cancer
Program Officer | Community Oncology and Prevention Trials |
| Whitman, Cynthia, B.S. [C] cynthia.whitman@nih.gov 240-276-7068 |
5E524 | Contractor | Community Oncology and Prevention Trials |
Grants
| PI Name Sort descending | PI Organization | Title | Grant Number | Program Official |
|---|---|---|---|---|
| Xu, Chunhui | Emory University |
High-throughput assessment of chemotherapy-induced cardiotoxicity in 3D human cardiomyocytes | 1R21CA285254-01A1 | Eileen Dimond, R.N., M.S. |
| Yeh, Jennifer M. | Boston Children'S Hospital |
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future | 5R01CA227576-05 | Eileen Dimond, R.N., M.S. |
| Yeh, Jennifer M. | Boston Children'S Hospital |
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care | 5R01CA261874-03 | Eileen Dimond, R.N., M.S. |
| Yu, Anthony Francis | Sloan-Kettering Inst Can Research |
Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial | 5R37CA273923-03 | Eileen Dimond, R.N., M.S. |